Free Trial

Eagle Pharmaceuticals (EGRX) Short Interest Ratio & Short Volume

Eagle Pharmaceuticals logo
$3.00 0.00 (0.00%)
As of 10/3/2025 03:59 PM Eastern

Eagle Pharmaceuticals Short Interest Data

Eagle Pharmaceuticals (EGRX) has a short interest of 42,200 shares. This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 13.6, indicating that it would take 13.6 days of the average trading volume of 6,184 shares to cover all short positions.

Current Short Interest
42,200 shares
Previous Short Interest
42,200 shares
Change Vs. Previous Month
No Change
Dollar Volume Sold Short
$157.20 thousand
Short Interest Ratio
13.6 Days to Cover
Last Record Date
September 15, 2025
Outstanding Shares
12,987,000 shares
Percentage of Shares Shorted
0.32%
Today's Trading Volume
18,634 shares
Average Trading Volume
6,184 shares
Today's Volume Vs. Average
301%
Short Selling Eagle Pharmaceuticals?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Eagle Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Get Report
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History

EGRX Short Interest Over Time

EGRX Days to Cover Over Time

EGRX Percentage of Float Shorted Over Time

Eagle Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
9/15/202542,200 shares $157.20 thousand No ChangeN/A13.6 $3.73
8/31/202542,200 shares $130.40 thousand +0.2%0.5%105.5 $3.09
8/15/202542,100 shares $134.72 thousand -0.2%N/A38.3 $3.20
7/31/202542,200 shares $155.72 thousand -1.4%0.5%60.3 $3.69
7/15/202542,800 shares $160.07 thousand +1.4%N/A6.5 $3.74
6/30/202542,200 shares $122.38 thousand -0.7%0.5%9 $2.90
6/15/202542,500 shares $102 thousand No Change0.5%2.6 $2.40
5/31/202542,500 shares $80.75 thousand -21.9%0.5%6.4 $1.90
5/15/202554,400 shares $105.54 thousand -14.7%N/A24.7 $1.94
4/30/202563,800 shares $125.05 thousand -43.4%N/A2.3 $1.96
4/15/2025112,800 shares $203.04 thousand -0.1%N/A3.7 $1.80
3/14/2025112,500 shares $146.25 thousand No ChangeN/A13.4 $1.30
2/28/2025112,500 shares $135 thousand -8.8%N/A5.4 $1.20
2/14/2025123,400 shares $144.38 thousand -63.5%N/A8.2 $1.17
1/31/2025337,700 shares $270.16 thousand -6.5%N/A13.8 $0.80
1/15/2025361,000 shares $223.82 thousand +0.3%N/A34.7 $0.62
9/30/2024371,600 shares $1.39 million +6.0%2.9%1.7 $3.73
9/15/2024350,500 shares $1.51 million -17.3%3.1%2.4 $4.31
8/31/2024423,800 shares $2.18 million -12.5%3.7%2.9 $5.14
8/15/2024484,200 shares $1.93 million +14.1%4.2%3.1 $3.98
7/31/2024424,400 shares $2.05 million -44.9%3.7%2.5 $4.82
7/15/2024770,600 shares $4.60 million -16.8%6.7%4.5 $5.97
6/30/2024925,900 shares $5.19 million -6.9%8.1%5.2 $5.60
6/15/2024994,400 shares $3.83 million -7.9%8.7%6.7 $3.85
5/31/20241,080,000 shares $3.75 million -5.3%9.5%7.1 $3.47
5/15/20241,140,000 shares $5.26 million -5.0%10.0%7.8 $4.61
4/30/20241,200,000 shares $4.91 million +1.7%10.5%7.7 $4.09
4/15/20241,180,000 shares $6.14 million -2.5%10.3%5.9 $5.20
3/31/20241,210,000 shares $6.34 million +4.3%10.6%5.3 $5.24
3/15/20241,160,000 shares $7.02 million +4.5%10.2%5 $6.05
2/29/20241,110,000 shares $6.50 million +4.7%9.7%4.3 $5.86
2/15/20241,060,000 shares $6.20 million +33.2%9.3%3.6 $5.85
1/31/2024796,100 shares $4.67 million +10.1%7.0%2.8 $5.86
1/15/2024723,100 shares $3.28 million +3.7%6.4%2.9 $4.53
12/31/2023697,400 shares $3.65 million +3.9%6.2%3.4 $5.23
12/15/2023671,300 shares $3.11 million +13.7%5.9%3.6 $4.63
11/30/2023590,400 shares $3.45 million -0.7%5.2%3.9 $5.85
11/15/2023594,600 shares $5.25 million -3.7%5.2%5.2 $8.83
10/31/2023617,600 shares $8.48 million +2.4%5.5%5.8 $13.73
10/15/2023602,900 shares $8.10 million +12.5%5.3%4.9 $13.43
9/30/2023536,000 shares $8.45 million -23.9%4.7%4.1 $15.77
9/15/2023704,600 shares $11.42 million +9.9%6.2%5.2 $16.21
8/31/2023640,900 shares $10.86 million -6.1%5.7%3.3 $16.95
8/15/2023682,400 shares $11.63 million +4.5%6.0%3.4 $17.04
7/31/2023653,200 shares $13.56 million -4.0%5.7%3.2 $20.76
7/15/2023680,200 shares $12.50 million +14.6%6.0%3.6 $18.37
6/30/2023593,600 shares $11.54 million -26.9%5.2%3.2 $19.44
6/15/2023812,500 shares $15.41 million +18.6%7.1%4.2 $18.96
5/31/2023685,200 shares $14.22 million -1.3%6.0%4.1 $20.75
5/15/2023694,400 shares $14.60 million -3.0%6.1%4.3 $21.03
4/30/2023715,700 shares $20.10 million -5.1%6.3%4.7 $28.08
4/15/2023754,400 shares $22.41 million -19.7%6.7%4.8 $29.71
3/31/2023939,300 shares $26.65 million -7.9%8.3%5.5 $28.37
3/15/20231,020,000 shares $26.27 million +16.4%9.0%6.3 $25.75
2/28/2023876,100 shares $24.53 million +1.0%7.8%6.1 $28.00
2/15/2023867,400 shares $26.73 million -0.8%7.7%6.3 $30.82
1/31/2023874,400 shares $29.68 million -9.7%7.7%5.8 $33.94
1/15/2023968,700 shares $31.43 million -2.4%8.6%6.2 $32.45
12/30/2022992,100 shares $29.00 million +63.8%8.8%6.4 $29.23
12/15/2022605,700 shares $17.90 million -27.0%5.4%3.6 $29.55
11/30/2022830,100 shares $30.15 million -9.4%7.3%4.9 $36.32
11/15/2022915,900 shares $33.89 million +0.1%8.1%5.3 $37.00
10/31/2022915,200 shares $28.80 million -6.5%8.1%4.9 $31.47
10/15/2022978,700 shares $27.01 million +8.4%8.5%5.6 $27.60
9/30/2022903,200 shares $23.86 million +28.8%7.8%5.4 $26.42
9/15/2022701,400 shares $21.13 million -17.2%6.1%4.3 $30.12
8/31/2022846,900 shares $27.75 million +3.2%7.4%5.7 $32.77
8/15/2022820,900 shares $29.49 million -18.7%7.2%5.6 $35.92
7/31/20221,010,000 shares $40.10 million +1.0%9.2%7.4 $39.70
7/15/20221,000,000 shares $44.83 million -2.9%9.1%7.5 $44.83
6/30/20221,030,000 shares $45.76 million -7.2%9.4%7.6 $44.43
6/15/20221,110,000 shares $48.33 million +17.4%10.2%8 $43.54
5/31/2022945,600 shares $44.16 million +4.3%8.6%6.8 $46.70
5/15/2022906,800 shares $39.90 million +8.2%8.3%6.8 $44.00
4/30/2022838,200 shares $36.99 million +20.1%7.7%6.4 $44.13
4/15/2022697,800 shares $35.20 million -3.1%6.4%5.5 $50.44
3/31/2022719,800 shares $35.62 million +4.4%N/A5.5 $49.49
3/15/2022689,700 shares $34.69 million +14.0%6.3%5.9 $50.30
2/28/2022604,900 shares $28.67 million -10.2%5.4%4.8 $47.39
2/15/2022673,200 shares $32.15 million +1.1%6.0%5.6 $47.76
1/31/2022665,700 shares $30.58 million +12.4%5.9%5.9 $45.94
1/15/2022592,400 shares $27.97 million +2.3%N/A5.6 $47.21
12/31/2021579,300 shares $29.50 million -1.0%5.2%6 $50.92
12/15/2021585,100 shares $30.60 million -5.5%5.2%5.8 $52.30
11/30/2021618,900 shares $29.51 million -3.3%5.5%7.1 $47.68
11/15/2021639,900 shares $32.62 million -7.1%5.7%6.9 $50.98
10/29/2021689,000 shares $36.08 million -1.7%6.0%7 $52.37
10/15/2021701,000 shares $38.12 million -11.3%6.1%7 $54.38
9/30/2021790,700 shares $44.11 million -4.8%6.9%7.6 $55.78
9/15/2021830,500 shares $43.92 million -3.3%7.3%7.2 $52.88
8/31/2021859,200 shares $45.86 million -6.7%7.5%7.4 $53.37
8/13/2021920,800 shares $44.91 million -5.0%8.1%7.7 $48.77
7/30/2021969,000 shares $45.06 million +4.6%8.5%8.5 $46.50
7/15/2021926,100 shares $43.55 million -3.1%8.1%8.1 $47.02
6/30/2021955,800 shares $40.91 million -7.2%8.4%8.1 $42.80
6/15/20211,030,000 shares $42.73 million -2.8%9.0%9.3 $41.49
5/28/20211,060,000 shares $42.00 million -1.9%9.3%10.1 $39.62
5/14/20211,080,000 shares $43.92 million +2.9%9.4%9.8 $40.67
4/30/20211,050,000 shares $42.98 million -7.9%9.2%9.1 $40.93
4/15/20211,140,000 shares $49.44 million -16.8%N/A0 $43.37
3/31/20211,370,000 shares $56.25 million -2.1%12.2%11.2 $41.06
3/15/20211,400,000 shares $62.97 million No Change12.4%11 $44.98
2/26/20211,400,000 shares $64.09 million +7.7%12.4%10.8 $45.78
2/12/20211,300,000 shares $62.41 million -7.1%11.6%10.7 $48.01
1/29/20211,400,000 shares $65.63 million -2.1%12.4%11.7 $46.88
1/15/20211,430,000 shares $72.54 million -4.0%12.7%11.4 $50.73
12/31/20201,490,000 shares $69.29 million No Change13.2%11.5 $46.50
12/15/20201,490,000 shares $68.81 million -0.7%13.2%10.6 $46.18
11/30/20201,500,000 shares $70.97 million -3.9%13.3%10.2 $47.31
11/15/20201,560,000 shares $76.30 million -4.9%13.8%9.6 $48.91
10/30/20201,640,000 shares $75.74 million -12.3%14.5%9.8 $46.18
10/15/20201,870,000 shares $85.03 million -18.0%15.9%10.6 $45.47

EGRX Short Interest - Frequently Asked Questions

What is Eagle Pharmaceuticals' current short interest?

Short interest is the volume of Eagle Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of September 15th, investors have sold 42,200 shares of EGRX short. Learn More on Eagle Pharmaceuticals' current short interest.

What is a good short interest ratio for Eagle Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EGRX shares currently have a short interest ratio of 14.0. Learn More on Eagle Pharmaceuticals's short interest ratio.

How does Eagle Pharmaceuticals' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Eagle Pharmaceuticals: Cassava Sciences, Inc. (12.19%), Oncolytics Biotech Inc. (2.61%), Pyxis Oncology, Inc. (9.88%), Cardiff Oncology, Inc. (22.94%), Greenwich LifeSciences, Inc. (20.13%), Climb Bio, Inc. (1.50%), Invivyd, Inc. (4.69%), Zhengye Biotechnology Holding Limited (4.29%), Compugen Ltd. (1.06%), TuHURA Biosciences, Inc. (7.73%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Corporation ($8.81 billion), Canadian Natural Resources Limited ($5.82 billion), Reddit Inc. ($5.19 billion), Coinbase Global, Inc. ($4.52 billion), Robinhood Markets, Inc. ($4.30 billion), Charter Communications, Inc. ($3.75 billion), CoreWeave Inc. ($3.66 billion), Seagate Technology Holdings PLC ($3.57 billion), Live Nation Entertainment, Inc. ($3.33 billion), and Rocket Lab Corporation ($3.26 billion). View all of the most shorted stocks.

What does it mean to sell short Eagle Pharmaceuticals stock?

Short selling EGRX is an investing strategy that aims to generate trading profit from Eagle Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Eagle Pharmaceuticals?

A short squeeze for Eagle Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of EGRX, which in turn drives the price of the stock up even further.

How often is Eagle Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EGRX, twice per month. The most recent reporting period available is September, 15 2025.




This page (NASDAQ:EGRX) was last updated on 10/6/2025 by MarketBeat.com Staff
From Our Partners